InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (31 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
31
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Cheng Andrew, Chief Executive Officer. Officer active across 2 companies, notably Akero Therapeutics, Inc.. Cumulatively, 75 disclosures have been published. Breakdown: 0 buy · 31 sells. Total volume traded: €15.4m. Activity tracked since 2 July 2021. The latest transaction was filed on 20 November 2025 (Don). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Cheng Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations75 total
277,075 sharesCommon StockSEC:0001193125-25-312131:0
159,762 sharesCommon StockSEC:0001193125-25-312131:1
74,538 shares0Common StockSEC:0001193125-25-291688:0
14,739 shares0Common StockSEC:0001193125-25-280748:0
30,000 shares@ US$19.872.5% of flowCommon StockSEC:0001193125-25-239343:0
30,000 shares@ US$53.9786.7% of flowCommon StockSEC:0001193125-25-239343:1
52,212 shares@ US$0.6150.1% of flowCommon StockSEC:0001193125-25-236151:0
13,022 shares@ US$6.3640.3% of flowCommon StockSEC:0000950170-25-114661:0
10,795 shares@ US$48.072.1% of flowCommon StockSEC:0000950170-25-108232:0
14,686 shares@ US$50.573.1% of flowCommon StockSEC:0000950170-25-095409:0
890 shares@ US$23.8680.1% of flowCommon StockSEC:0000950170-25-093316:0
6,620 shares@ US$54.841.6% of flowCommon StockSEC:0000950170-25-088641:0
14,842 shares@ US$53.763.6% of flowCommon StockSEC:0000950170-25-085674:0
7,200 shares@ US$41.001.3% of flowCommon StockSEC:0000950170-25-070811:0
22,800 shares@ US$41.6344.1% of flowCommon StockSEC:0000950170-25-070811:1
30,000 shares@ US$35.2264.5% of flowCommon StockSEC:0000950170-25-053391:0
1,738 shares@ US$44.880.3% of flowCommon StockSEC:0000950170-25-039765:0
28,784 shares@ US$41.7465.3% of flowCommon StockSEC:0000950170-25-038177:0
6,439 shares@ US$52.9081.6% of flowCommon StockSEC:0000950170-25-018311:1
749 shares@ US$54.5460.2% of flowCommon StockSEC:0000950170-25-018311:3
12,640 shares@ US$51.7523.1% of flowCommon StockSEC:0000950170-25-018311:0
9,972 shares@ US$53.6662.5% of flowCommon StockSEC:0000950170-25-018311:2
200 shares@ US$55.810.1% of flowCommon StockSEC:0000950170-25-018311:4
24,242 shares@ US$54.566.1% of flowCommon StockSEC:0000950170-25-010705:0
50,000 shares@ US$0.6150.1% of flowCommon StockSEC:0000950170-25-009324:0
25 of 75 declarations
About Cheng Andrew
Cheng Andrew is Directeur Général and reports transactions in Akero Therapeutics, Inc. and Vera Therapeutics, Inc. He has 75 filings in total, and in the recent sampled filings the transactions are sales totaling EUR 15361120 between 2021-05-18 and 2025-12-09, with Levée d'options as the most frequent transaction type.
